ProPublica’s Liz Moughon tells about the investigation into the unprecedented safety recall of America’s most popular CPAP machines. Listen below by pressing blue arrow. Subscribe to both of Sharyl’s podcasts: “The Sharyl Attkisson Podcast” and “Full Measure After Hours.” Leave […]
After Hours: Behind the Giant CPAP Machine Recall (Podcast) Read More »
After the horrific ship collision that took down a major bridge in Baltimore, Maryland, President Biden promised taxpayers, not the shipping company or its insurance, would pick up the tab to rebuild the bridge. In the wake of such emergencies,
Dr. Robert Lufkin gives us a look inside his new book: “Lies I Taught in Medical School.”
For whatever reason, America’s health officials haven’t seemed publicly interested in answering a crucial question: How many illnesses and deaths can be attributed to COVID versus the vaccines or some combination? Today, we look at shocking and graphic evidence that
The COVID experience ignited a movement within mainstream medicine among doctors who say their institutions or the government barred them from helping their patients. Hundreds of like-minded medical professionals recently gathered in Phoenix, Arizona for a third annual conference, where
In recent days, Colorado Representative Lauren Boebert announced she had emergency surgery for a blood clot and was diagnosed with an iliac vein problem called May-Thurner syndrome. Though it’s impossible to know the root cause, we’ve been reporting on a
Americans have never spent more on health care. At the same time, we are growing sicker and dying sooner, according to experts. While the average patient may not seem to be benefiting from all the money flooding in into the
Health care billionaires stay rich as America gets sicker Read More »
The following is from Public Citizen. Amylyx Pharmaceuticals said on Thursday that it would withdraw AMX0035 (sodium phenylbutyrate and taurursodiol, sold as Relyvrio) from the market. A large clinical trial recently found that the drug did not provide any benefit to patients
Drug manufacturer Amylyx pulls ALS drug Relyvrio from market, citing lack of efficacy Read More »
